Abnormal migration of human aortic smooth muscle cells (HASMCs) causes intimal thickening of the aorta, a pivotal step in atherosclerotic development. Although many studies have demonstrated that high anthocynidins intake confers protective effects against atherosclerosis, the direct molecular targets, and mechanisms of action responsible remain unclear. Here, we investigated the preventive effect of anthocyanidins on atherosclerosis and the underlying mechanisms involved.
Introduction
Aortic smooth muscle cells (ASMCs) are a major constituent of the media layer of aortic blood vessels. The abnormal migration of ASMCs into the intima layer induces thickening of the aorta, which is a pivotal step in the development of atherosclerosis. 1 After migrating to the intima, however, ASMCs lose their original function of controlling vessel contraction and accumulate in the inner vessel with lipid-laden macrophages. This ultimately leads to vessel occlusion, resulting in the development and progression of atherosclerosis. Abnormal migration of ASMCs can be triggered by excessive expression of various cytokines and growth factors, especially the platelet-derived growth factor (PDGF). 2 PDGF regulates various cell phenotypes, including migration. It is a dimeric protein arising from four different genes (PDGF-A, B, C, and D). Among the isoforms, PDGF-BB triggers the strongest signal transduction due to its ability to bind with all isoforms of the PDGF receptor (PDGFR). 3 Receptor activation by PDGF subsequently induces various cell signalling factors, including focal adhesion kinase (FAK), phosphoinositide-3-kinase (PI3 K)/Akt, and mitogen-activated protein kinases (MAPKs), which all play a crucial role in the migration of ASMCs.
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FAK, protein tyrosine kinase 2, is a non-receptor tyrosine kinase that regulates diverse cellular phenotypes, including motility. 5, 6 Growth factors, including PDGF and integrin, can induce auto-phosphorylation of FAK at Tyr397. This generates an SH2-binding site for Src which in turn phosphorylates other tyrosine residues, including Tyr566 and Tyr567, which are required for the full activation of FAK. 7, 8 In the vascular system, FAK plays pivotal roles in the vasculature development through the regulation of SMC recruitment and endothelial vascular network formation. Depletion of FAK has been reported to block SMC motility induced by PDGF. 9, 10 Recent studies have revealed that the FAK-related non-kinase can inhibit SMC migration. 11, 12 Anthocyanidins are plant pigments abundant in various coloured plants. 13 Petunidin, delphinidin, cyanidin, pelargonidin, malvidin, and peonidin ( Figure 1A ) are six subtypes that represent the majority of plant anthocyanidins. Epidemiological studies have revealed that frequent consumption of high-anthocyanin-containing foods is associated with a lower risk of cardiovascular diseases. 14, 15 There are multiple lines of evidence demonstrating anti-inflammatory and anti-tumourigenic effects of anthocyanidins. 16 -19 However, the majority of studies has mainly focused on the effect of several anthocyanidins on tumourigenesis. Although some studies have reported the potential anti-atherosclerotic effects of anthocyanidins, 20, 21 the underlying molecular mechanisms and their direct targets remain unclear.
In this study, we tested the effects of six anthocyanidins on PDGF-BB-induced migration of HASMCs. Our results demonstrate that some anthocyanidins are natural inhibitors of FAK and suppress PDGF-BB-induced HASMC migration and neointima formation in vivo.
Methods

Chemicals
Anthocyanidins purified by HPLC were obtained from Chromadex (Irvine, CA, USA) and PF-228 was acquired from Tocris Bioscience (Bristol, UK). PDGF-BB was supplied by R&D Systems (Minneapolis, MN, USA) and MCDB131 medium, streptomycin/penicillin, insulin, foetal bovine serum (FBS), and L-glutamine were purchased from Gibco-BRL (Carlsbad, CA, USA). Epidermal growth factor (EGF) and basic fibroblast growth factor (bFGF), antibodies against phosphorylated FAK for each site (Tyr397, Tyr566, or Tyr567), and Alexa Fluor 568-phalloidin were obtained from Invitrogen (Carlsbad, CA, USA). Active FAK protein and total FAK and total Src antibodies were purchased from Upstate Biotechnology (Lake Placid, NY, USA). Antibodies for phosphorylated ERK (Tyr202/Tyr204), phosphorylated Akt (Ser473), total ERK, total JNK, and His-probe were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Phosphorylated Src, phosphorylated JNK1/2, phosphorylated p38MAPK, total p38MAPK, and total Akt antibodies were obtained from Cell Signaling Biotechnology (Beverly, MA, USA). Matrigel was obtained from BD Biosciences (San Jose, CA, USA). a-Smooth muscle actin (SMA) fluorescein isothiocyanate (FITC) conjugated antibody and ticlopidine were purchased from Sigma (St Louis, MO, USA). CNBr-Sepharose 4B was supplied by GE Healthcare and protein-G-agarose was acquired from KPL Corporation (Gaithersburg, MD, USA). [g-32 P ]ATP was purchased from the Institute of Isotopes Co. Ltd (Budapest, Hungary) and the protein quantification assay kit was obtained from Bio-Rad Laboratories (Hercules, CA, USA).
Cell culture
HASMCs originated from normal human tissue were obtained according to the principles outlined in the Declaration of Helsinki and supplied by Lonza (Walkersville, MD, USA). The cells were cultured at 378C in a 5% CO 2 incubator in MCDB131 media containing 10% FBS, 2 mM L-glutamine, 25 ng/mL EGF, 25 ng/mL bFGF, 5 ng/mL insulin, and streptomycin/penicillin. All experiments were performed with HASMCs between 7 and 13 passages.
Wound healing migration assay
Cell migration was assessed by a wound healing migration assay as previously described. 22 After confluence, serum-starved HASMCs were treated with mitomycin C for 30 min and subjected to injury using a 2 mm wide tip. They were then treated with PDGF-BB alone or together with anthocyanidins or PF-228 at the indicated concentrations. The cells were allowed to migrate, and images were taken through an inverted microscope (×100, magnification).
Boyden chamber migration assay
The Boyden chamber invasion assay was conducted as previously described 22 and performed using the Transwell system (Corning Costar, MA, USA). Briefly, cultured cells were re-suspended in media containing PDGF-BB or each sample and incubated for 12 h in the upper section of a Transwell plate and allowed to migrate to the filter's lower side media containing 0.1% BSA and PDGF-BB or each sample. HASMCs on the lower surface of filters were stained with haematoxylin and eosin (H&E). Ten randomly selected fields were counted, and each sample was assayed in triplicate.
Aortic sprouting assay
The experimental protocol was approved by the Animal Care and Use Committee of Seoul National University (SNU-201004-18). The aortic sprouting assay was assessed as previously described. 23 Animals were anaesthetized with an intraperitoneal (i.p.) injection of tiletamine/zolazepam 30 mg/kg (Zoletile, Virbac, Carros Cedex, France) and xylazine 10 mg/kg (Rompun, Bayer, Leverkusen, Germany), and perfused transcardially with phosphate buffered saline (PBS) before the thoracic artery was excised. Thoracic aorta rings were simultaneously treated with PDGF-BB and petunidin or PF-228 at the indicated concentrations in FBS-free medium. The rings were stained with methylene blue, photographed, and analysed for areas of sprouting using the Image J software on Day 5.
Balloon endothelial denudation
The experimental protocol was approved by the Animal Care and Use Committee of Seoul National University (SNU-130513-1). Male sprague-dawley (SD) rats weighing 280-320 g were anaesthetized with an i.p. injection of tiletamine/zolazepam (30 mg/kg) and xylazine (10 mg/kg). Balloon catheter denudation of the carotid artery except in the sham group was performed according to the method described previously 24 and technically supported by Dr K. Chang of Seoul St
Mary's Hospital (Seoul, Korea). HPLC-purified petunidin (Tokiwa Phytochemical Co., Tokyo, Japan) suspended in the vehicle (10% DMSO in saline) was administered a day after vascular injury at a dose of 1 (Pet_1) or 5 (Pet_5) mg/kg bodyweight through i.p. injection daily for 14 days. Ticlopidine 10 mg/kg/day (Ticlo_10) i.p. injection was used as a positive control. 25 The sham and injury groups received the same volume of the vehicle. All groups contained six rats.
Carotid artery histological analysis
On Day 15 after vascular injury, the rats were anaesthetized with an i.p. injection of tiletamine/zolazepam 30 mg/kg and xylazine 10 mg/kg and perfused transcardially with PBS and 1% paraformaldehyde before the left common carotid artery was excised. After post-fixation with 4% paraformaldehyde overnight, the arteries were embedded in paraffin and cut into 3 mm sections, followed by H&E staining. For the immunofluorescence study, arteries were embedded in tissue-freezing medium. Frozen blocks were cut into 10 mm sections and then stained with the a-SMA antibody. Later, the intimal/medial (I/M) ratio [(intimal area)/ (medial area)] and the width of the a-SMA-positive layer were examined by using the Image J software.
Immunoblotting
Total cell lysates were prepared and subjected to Immunoblot as described previously. 22 After cell lysis, the protein concentration was determined using a dye-binding protein assay kit (Bio-Rad Laboratories, Hercules, CA, USA) as described in the manufacturer's instructions.
Kinase assay
The in vitro kinase assay was carried out in accordance with the instructions provided by Upstate Biotechnology. The effects of anthocyanidins and PF-228 were evaluated by incubating each sample with the FAK reaction mixtures containing poly-Glu -Tyr substrate peptide and [g232 P ] ATP solution at 308C for 10 min. The ex vivo FAK immunoprecipitation and kinase assay were assessed as previously described.
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HASMC lysates stimulated with PDGF-BB for 5 min were immunoprecipitated with an FAK antibody and protein A/G agarose beads. These tubes were centrifuged and the pellets were washed. The radioactive incorporation was determined using a scintillation counter. Each experiment was performed three times.
Pull-down assays
Sepharose 4B powder was suspended in 1 mM HCl and 2 mg of each anthocyanidin was added to the coupling solution and mixed at 48C Atherosclerosis prevention effects of anthocyanidins overnight. The procedure was performed as reported previously. 17 For the pull-down assay, recombinant FAK (in vitro) or HASMC lysates (ex vivo) was incubated with petunidin-Sepharose 4B (or Sepharose 4B alone as a control) beads. Bounded proteins were analysed by immunoblotting. The ATP competition pull-down assay was conducted as previously described. 22 Briefly, 100 ng of active FAK was incubated with ATP at 48C overnight. After incubation, petunidin-Sepharose 4B or Sepharose 4B was added to FAK-ATP mixture for 2 h at 48C. The beads were then washed, and bounded proteins were analysed by immunoblotting.
Phalloidin staining
HASMCs grown in a glass chamber slide were serum starved for 24 h and treated with petunidin, peonidin, and PF-228 at the indicated concentrations for 1 h, before PDGF-BB was added. After 12 h treatment with PDGF, the cells were fixed in 4% MeOH-free paraformaldehyde in PBS for 20 min. After washing with PBS, the cells were permeabilized using 5% goat serum and 0.3% Triton-X in PBS for 10 min. After washing with PBS, cells were incubated with Alexa-Fluor 568-conjugated phalloidin for 1 h and the chamber slides were washed and embedded in Vectashield mounting medium.
Statistical analysis
Data are expressed as the means + SEM values. One-way analysis of variance (ANOVA) was used for comparisons in the experiments with multiple time points and concentrations. When ANOVA indicated statistical significance, Duncan's multiple range test was used to determine which means were significantly different. A probability value of P , 0.05 was used as the criterion for statistical significance.
Results
Anthocyanidins inhibit PDGF-BB-induced HASMsC migration
The abnormal migration of ASMCs into the intima layer is a prominent feature of the growth of atherosclerotic lesions. 1 To compare the potential atherosclerosis-preventive effects of anthocyanidins, we examined their anti-migratory effects using a wound healing migration assay. Among the six anthocyanidins, petunidin exhibited the strongest inhibitory effect on PDGF-BB-induced HASMC migration. Delphinidin and cyanidin exhibited relatively mild inhibitory effects, whereas peonidin did not show any effect ( Figure 1B) . Since petunidin exhibited the strongest effect against PDGF-BB-induced HASMC migration, we further investigated petunidin more deeply, as well as its molecular mechanisms of action.
Petunidin suppresses PDGF-BB-induced migration in HASMCs and aortic ring sprouting
To elucidate the anti-migratory effects of petunidin, we performed two types of migration assay. In both assays, petunidin suppressed PDGF-BB-induced HASMC migration in a dose-dependent manner, and .20 mM concentrations, petunidin abolished cell migration completely (Figure 2A and B) . Petunidin also inhibited PDGF-BB-induced HASMCs proliferation (see Supplementary material online, Figure S1 ). The concentrations at which petunidin exhibited anti-migratory effects were not cytotoxic towards HASMCs (data not shown).
To further investigate the anti-migratory effects of petunidin ex vivo, we employed an aortic ring assay. Photographic data revealed that cellsprouting areas of the aortic rings increased as a result of PDGF-BB treatment, whereas it was significantly reduced by petunidin treatment in a dose-dependent manner ( Figure 2C and D) . These results suggest that petunidin markedly attenuates PDGF-BB-induced ASMC migration both in vitro and ex vivo.
Petunidin attenuates balloon-injury induced carotid intimal thickening
To investigate the in vivo effect of petunidin, we used a model of balloon-injured carotid neointima formation. No significant body weight or liver weight loss or appearance changes were observed among all groups, indicating that the compound treatments were not toxic to the animals (data not shown). H&E staining data showed that 5 mg/kg petunidin treatment significantly suppressed neointima formation and the intimal/medial ratio ( Figure 3A and B) . The width of the a-SMA positive area, representing the ASMCs layer, 27 was increased by balloon injury, whereas it was markedly reduced by 1 and 5 mg/kg petunidin treatment ( Figure 3C and D). These in vivo results support that petunidin exhibits atherosclerosis-preventive effect through the inhibition of abnormality of ASMCs.
Petunidin inhibits PDGF-BB-induced FAK phosphorylation and activity by direct binding
To elucidate the inhibitory mechanisms of petunidin on HASMC migration, we next investigated the effects of petunidin on PDGF-BB-induced protein kinase signalling. Petunidin treatment dramatically reduced PDGF-BB-induced phosphorylation at Y397 as well as at Y566 and Y567 from 5 mM concentration. However, the phosphorylation of PDGFR-b (see Supplementary material online, Figure S2A ), Src, all three MAPKs and Akt ( Figure 4A and B) were inhibited only at 20 mM treatment. Since FAK phosphorylation was blocked by petunidin at a relatively lower concentration than the other signalling pathways, we hypothesized that FAK could be the primary molecular target of petunidin for the inhibition of migration in HASMCs. We then performed FAK activity assays with petunidin treatment. Petunidin strongly inhibited FAK activity in vitro ( Figure 4C ) and the results from the ex vivo FAK activity assay using PDGF-BB-treated HASMC lysates further supported this finding ( Figure 4D) .
To determine whether petunidin binds with FAK directly, we performed pull-down assays. In the in vitro pull-down assay using recombinant FAK protein, FAK bound to the petunidin beads but not to the control beads ( Figure 4E, upper panel) . We also observed ex vivo binding of petunidin with FAK in HASMC lysates ( Figure 4E, lower panel) . Binding between petunidin and FAK was not altered with increasing amounts of ATP ( Figure 4F) . Additionally, pre-treatment of FAK with PF-228, an ATPcompetitive FAK inhibitor, 28 did not affect the binding between petunidin and FAK (see Supplementary material online, Figure S2B ). FAK is important in endothelial cell homoeostasis, a critical aspect of vascular health. 29, 30 We thus assessed the effect of petunidin on HUVECs. Petunidin treatment did not inhibit HUVECs migration, proliferation, or FAK phosphorylation, whereas PF-228 exhibited dramatic inhibitory effects (see Supplementary material online, Figure S3 ). These results suggest that petunidin inhibits PDGF-BB-induced HASMC migration by direct suppression of FAK activity in an ATP non-competitive manner.
Anti-migration activity of anthocyanidins is dependent on FAK inhibition
To assess whether the differential effects of anthocyanidin on HASMC migration is related to their ability to inhibit FAK activity, we compared the effects of anthocyanidins on FAK phosphorylation and activity. Petunidin exhibited the strongest inhibitory effect on PDGF-BB-induced FAK phosphorylation, while cyanidin and delphinidin exhibited relatively mild effects ( Figure 5A ). FAK activity assay data also demonstrated that petunidin exerts the most potent effect on FAK inhibition compared with other anthocyanidins. These findings were in parallel to the migration and FAK phosphorylation results ( Figure 5B) . In pull-down assays using HASMC lysates, FAK was detected in the petunidin and delphinidin beads but not in the control, peonidin, or malvidin beads ( Figure 5C ), suggesting that some anthocyanidins attenuate FAK kinase activity by direct binding with the FAK protein. We also examined the effects of petunidin and peonidin on the filamentous actin cytoskeleton (F-actin), whose remodelling is known to be under control of FAK during cell migration. 31 Petunidin treatment recovered PDGF-BB-induced F-actin reduction in HASMCs, whereas peonidin did not show any effect ( Figure 5D ). The quantification of sprouting areas was conducted as described in Section 2. Data are represented as means + SEM values of at least three-independent experiments. The asterisks indicate a significant difference compared with the group exposed to PDGF-BB alone (*P , 0.05, **P , 0.01).
Atherosclerosis prevention effects of anthocyanidins These results suggest that the attenuation of FAK activity occurs through direct binding of anthocyanidins, blocking PDGF-BB-induced dynamic remodelling of the actin skeleton, and subsequently leads to inhibition of HASMC migration.
The inhibition of FAK activity in PDGF-BB-stimulated HASMCs reduces cell migration
We demonstrated that anthocyanidins can attenuate FAK activity and migration in PDGF-BB-treated ASMCs. We next examined the effects of the specific inhibition of FAK activity on PDGF-BB-induced migration in ASMCs and ex vivo aortic sprouting using a specific inhibitor of FAK, PF-228. PF-228 treatment blocked PDGF-BB-induced FAK phosphorylation ( Figure 6A ) and F-actin reduction ( Figure 6B ) in HASMCs. Treatment with PF-228 also completely inhibited PDGF-BB-induced HASMC migration in both migration assays ( Figure 6C and D) and inhibited PDGF-BB-induced aortic ring sprouting in a dose-dependent manner ( Figure 6E and F ) . FAK inhibition by PF-228 did not attenuate phosphorylation of Src, MAPKs, or Akt (see Supplementary material online, Figure S4 ). These results suggest that specific FAK inhibition in ASMCs is a critical mechanism for attenuation of abnormal ASMC migration, laying the potential foundation for a novel strategy for the prevention of atherosclerosis.
Discussion
Anthocyanidins are pigments existing in coloured fruits and vegetables and red wine. 13 The average daily intake of anthocyanins is 180-215 mg/day, relatively higher than that of other dietary flavonoids. 32 A previous study demonstrated that the maximum total anthocyanidin levels reached after oral administration of anthocyanin-rich extract in plasma was 5.7 mg/mL (cyanidin equivalent) in rats ( 19 mM, molecular weight of cyanidin: 287 g/mol). 33 Previous studies have reported potential anti-atherosclerotic effects for anthocyanidins and anthocyanin-rich extracts. 20,34 -36 However, the potential atherosclerosis preventive effects of anthocyanidins and their molecular mechanisms are not yet fully understood. In this study, we report that anthocyanidins directly suppress FAK activity, and subsequently attenuate F-actin reduction leading to the inhibition of PDGF-BB-induced HASMC migration and subsequently attenuate in vivo neointima formation.
To elucidate the molecular mechanisms of anthocyanidins in HASMC migrations, we further investigated petunidin, the most effective anthocyanidin for the inhibition of HASMC migration. Although the antioxidative properties of anthocyanidins may partially contribute to their beneficial effects, recent studies have suggested that polyphenols can directly regulate cell signalling. 37 Our data indicate that petunidin markedly blocks FAK phosphorylations at a relatively low concentration (5 mM). Petunidin also inhibited kinase activity in vitro and ex vivo by direct binding to FAK in an ATP non-competitive manner. Moreover, we found that the extent of anti-migratory effects of anthocyanidin corresponds with the extent of FAK inhibition. Thus, we conclude that the modulation of FAK kinase activity by anthocyanidins appears essential for the antimigratory effect in ASMCs. Some molecular targets of anthocyanidins have been reported. According to previous studies, some kinases have been identified as target proteins of anthocyanidins. 17, 19, 38, 39 In the current study, petunidin at high concentrations inhibited phosphorylation of PDGFR, Src, MAPKs, and Akt, whereas PF-228 did not, suggesting the possibility that at high concentrations, other targets of anthocyanidins, such as PDGFR could exist. FAK plays a crucial function in regulating cell growth, migration, and invasion. 40 Even though FAK inhibition can exert inhibitory effects on vascular pathogenesis, 41 there have been no reports of using FAK inhibitors for atherosclerosis prevention. In this study, we demonstrated that anthocyanidins have potent inhibitory effects against FAK activity and PDGF-BB-induced HASMC migration and aortic sprouting. A synthetic FAK inhibitor, PF-228, also caused reductions in HASMC migration and aortic sprouting, supporting the notion that inhibition of FAK in ASMCs could lead to the prevention of atherosclerosis via suppressing abnormal ASMC migration. FAK regulates endothelial cell survival, growth, and migration. 30, 42, 43 Therefore, even if FAK inhibition by petunidin can block ASMC migration, such treatment may have adverse effects on endothelial cells whose function is to protect against atherosclerosis. However, petunidin exhibits such inhibitory effects only against PDGF-BB-induced HASMCs, and not against HUVECs, whereas PF-228 attenuated both cell types. A likely interpretation for this potential discrepancy is that petunidin's ability to maintain signalling homoeostasis for antiatherosclerotic effects is dependent upon cell type, just as polyphenol compounds have been found that bind and inhibit diverse signalling molecules, dependent upon cell types. 44 Although FAK inhibition levels by anthocyanidins were relatively weaker than that achieved by the synthetic FAK inhibitor, natural small molecule inhibitors already found in common foods are generally regarded as safer due to their long history of human consumption. Our results suggest that FAK is a direct molecular target of anthocyanidins, responsible for their potential atherosclerotic prevention effects. We have shown that some anthocyanidins can exhibit inhibitory effects on PDGF-BB-induced HASMC migration and neointima formation in vivo, and FAK might be a molecular target of anthocyanidins. Further research to understand how these anthocyanidins exert differential HASMCs were grown in glass chambers. After pre-treating the serum-starved HASMCs with PF-228 for 1 h, the cells were stimulated with PDGF-BB. The formations of F-actin were determined by Alexa Fluor-phalloidin staining as described in Section 2. (C) Serum-starved HASMCs were pre-treated with PF-228 for 1 h before adding PDGF-BB. Results are expressed as the widths of injury lines relative to untreated controls at 0 h as determined from three independent experiments. (D) HASMCs seeded in the inner chamber in serum-free media were exposed to PF-228 with PDGF-BB for 12 h. Results are expressed as the number of migrated cells relative to untreated controls as determined from three independent experiments. (E and F ) Aortic rings embedded in Matrigel were treated with PDGF-BB and PF-228 as indicated. All images were obtained on Day 5 of treatment. (E) Light microscopy images showing the effects of PF-228 on PDGF-BB-induced sprout formation. (F) Quantification of sprouting areas was conducted as described in Section 2. Data are represented as means + SEM values of at least three-independent experiments. The asterisks indicate a significant difference compared with the group exposed to PDGF-BB alone (*P , 0.05, **P , 0.01).
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